{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:46:15Z","timestamp":1787496375268,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25430123"],"award-info":[{"award-number":["25430123"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26440058"],"award-info":[{"award-number":["26440058"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbrc.2014.10.086","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T19:00:00Z","timestamp":1414177200000},"page":"364-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin \u03b21-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway"],"prefix":"10.1016","volume":"454","author":[{"given":"Rina","family":"Takamiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ariki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.10.086_b0005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2217\/fon.13.92","article-title":"Role of hypoxia-inducible factors in breast cancer metastasis","volume":"9","author":"Gilkes","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrc.2014.10.086_b0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI69244","article-title":"Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis","volume":"123","author":"Chaturvedi","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.10.086_b0015","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1038\/onc.2012.578","article-title":"Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis","volume":"32","author":"Semenza","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.10.086_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia \u2013 a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2014.10.086_b0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2014.10.086_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1568009611313030003","article-title":"Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer","volume":"13","author":"Agani","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2014.10.086_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2014.10.086_b0040","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1007\/s00018-007-7120-0","article-title":"Role of heregulin in human cancer","volume":"64","author":"Breuleux","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2014.10.086_b0045","first-page":"131","article-title":"Regulation of HRG-beta1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression","volume":"6","author":"Ruan","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2014.10.086_b0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/1471-2407-13-383","article-title":"HRG-beta1-driven ErbB3 signaling induces epithelial\u2013mesenchymal transition in breast cancer cells","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2014.10.086_b0055","doi-asserted-by":"crossref","first-page":"32910","DOI":"10.1074\/jbc.M113.491902","article-title":"Suppression of heregulin beta signaling by the single N-glycan deletion mutant of soluble ErbB3 protein","volume":"288","author":"Takahashi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.10.086_b0060","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.10.086_b0065","article-title":"Sequestosome 1\/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways","author":"Cai-McRae","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.10.086_b0070","doi-asserted-by":"crossref","first-page":"E2120","DOI":"10.1073\/pnas.1406655111","article-title":"Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment","volume":"111","author":"Chaturvedi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.086_b0075","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1038\/ncomms5715","article-title":"Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2014.10.086_b0080","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1038\/onc.2009.244","article-title":"Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity","volume":"28","author":"Switzer","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.10.086_b0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.semcancer.2012.05.002","article-title":"A new paradigm for mechanobiological mechanisms in tumor metastasis","volume":"22","author":"Torzilli","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2014.10.086_b0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12282-011-0321-2","article-title":"The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis","volume":"19","author":"Imamura","year":"2012","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bbrc.2014.10.086_b0095","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1158\/0008-5472.CAN-13-0712","article-title":"KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer","volume":"73","author":"Dai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.10.086_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1535-6108(02)00023-5","article-title":"Functional genomics and the breast cancer problem","volume":"1","author":"Ince","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2014.10.086_b0105","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1158\/0008-5472.CAN-13-0687","article-title":"Optimal targeting of HER2-PI3K signaling in breast cancer: mechanistic insights and clinical implications","volume":"73","author":"Rexer","year":"2013","journal-title":"Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14018956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14018956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T03:50:03Z","timestamp":1538106603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14018956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0006291X14018956"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.086","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin \u03b21-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}